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Abstract 
Studies examining effects of doping in professional road racing building on archival records of the 
three major European stage races—the Tour de France, Giro d’Italia, and Vuelta a España—con- 
cluded that riders’ final performances in the “epo era” (>1990) strongly improved, yet declined 
since 2004. These observations can be criticized. First, we argue that time trial performances are 
more valid than final performances to indirectly evaluate doping effects. Second, we will pay at-
tention to an informal logical flaw—the Texas sharpshooter fallacy—which may have biased find-
ings and conclusions presented in the studies. To empirically substantiate our critique, we ana-
lyzed mean kilometers per hour (km/h) performances realized by winning riders in all time trials 
on flat and rolling terrain in the three tours (1933-2013, N = 325). Regression analyses revealed 
no evidence for nonlinear in- or decreases in riders’ speed beyond the 1990s, but a straightfor-
ward linear progress over time of b = 0.16 km/h per year (R2 = 0.50, p ≤ 0.001). Findings corrobo-
rate our comments on previous archival studies and qualify opinions about effects of the “epo ep-
idemic” on cyclists’ achievements, since the time trial performances delivered in these years are 
no exemption to the observed linear progress in speed. 
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1. Introduction 
An increasing number of doping scandals plagued the cycling world the last twenty years [1]. The most recent 
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incident, evoking impassioned societal debates and worldwide media coverage, concerns American ex-professional 
cyclist Lance Armstrong. According to the United States Anti-Doping Agency [2] [3] (p. 5) he was involved in 
“a massive team doping scheme, more extensive than any previously revealed in professional sports history”. To 
indirectly examine effects of doping in professional cycling, El Helou et al. [4] and Perneger [5] assessed riders’ 
speed progress over time based on archival records of the three European Grand Tours (Tour de France, Giro 
d’Italia, and Vuelta a España). They reported significance in- and decreases in riders’ final kilometers per hour 
(km/h) performances beyond the 1990s. However, as will be delineated below, these studies may suffer from 
methodological errors. First, we will pay attention to the dependent variable used in these studies to indirectly 
appraise effects of doping agents on riders’ speed, arguing that time trial performances are more suitable than 
final performances to critically examine these effects. Second, we will focus on an informal logical flaw—the 
Texas sharpshooter fallacy—which may have led to a misrepresentation of developments in cyclists’ perfor-
mance progress in the three tours in the epo era. 
1.1. The Epo Era in Professional Cycling 
The use of the banned, artificial glycoprotein hormone erythropoietin, or epo, became widespread in endurance 
sports such as cycling in the beginning of the 1990s [6]. Verbruggen [7], former president of the International 
Cycling Union (UCI), the sports’ governing body, agrees with this view. So does Vandeweghe [1], chairman of 
the Flanders Cycling Federation (WBV, Wielerbond Vlaanderen). Both maintain that epo doping enhances en-
durance performance by as much as 20 percent. Other studies, which examined annals of the cycling sport, ap-
pear to support these statements. Perneger [5] investigated mean km/h performances of riders who ranked fifth 
in the overall standings of the three major tours in the period 1990-2009. He reported that between 1990 and 
2004, riders’ speed increased by 0.16 km/h per year and further observed a decrease in speed of 0.22 km/h per 
year since 2004. In 2001, the World Anti-Doping Agency (WADA [8]) implemented a direct test for epo, while 
a test for homologous blood transfusions (blood harvested from a compatible donor) was put into operation at 
the 2004 Summer Olympic Games in Athens [8]. Perneger [5] attributed the incline in riders’ speed to illicit 
doping practices and interpreted the decline since 2004 as evidence for the successes of WADA’s policy. El 
Helou et al. [4] also investigated archival data of the cycling sport using a time-series model. They analyzed 
mean km/h performances of riders who reached the first ten places in the final rankings of eleven European rac-
es from 1892 to 2008, which included all famous one-day classic races as well as the three major European stage 
races. Their analyses yielded four distinct periods: Before WW I (P1), between the two world wars (P2), after 
World War II (P3), while the fourth period (P4) starts after 1993. They reported that, relative to the third period 
(1946-1992), riders’ performances in the fourth period (1993-2008) showed an improvement in speed of 6.38%. 
Notice that their fourth period collides with the years of the epo era. They further put forward that the improve-
ment they observed agreed with the 6.3% - 6.9% increase in aerobic exercise capacity found in laboratory stu-
dies assessing the performance-enhancing (or ergogenic) effects of epo administration on this capacity. However, 
in their review of epo studies, Lundby and Olsen [9] estimated improvements of 8% - 12%, while Vandeweghe 
[1] and Verbruggen [7] mentioned improvements up to 20%. These divergent estimates indicate disagreement 
between sources about these improvements. 
1.2. Time Trial vs. Final Performances 
Lodewijkx and Brouwer [10] [11] criticized the conclusions of the two historic studies alluded to above, but we 
will refrain from re-iterating these comments in the current paper. Importantly for the present thesis, in another 
study, Lodewijkx and Verboon [12] argued that these studies inappropriately used individual riders’ ultimate 
km/h performances as the dependent variable to evaluate effects of doping use on their achievements over the 
years. The study compared Armstrong’s time trial wins, realized in the Tour de France (1999-2005), to perfor-
mances of other riders who, from 1934 to 2010, won similar races in the three major tours facing trial distances 
comparable to Armstrong’s (50 - 61 km). Findings indicated that, initially, he did realize significantly faster 
performances relative to the other riders (M = 4.70 km/h, p ≤ 0.05, R2 = 0.064). However, after statistically con-
trolling for the significant influence of competition year, he ultimately raced somewhat slower (M = −0.43 km/h, 
p = 0.80, R2 = 0.001). Only one of his wins exceeded the bounds of the 68%-CI (i.e., ±1SD from the sample 
mean), while all his remaining six achievements fell within the bandwidth of this very stringent criterion. Thus, 
when considering the historic performance variation in these trials of limited distance, all individual accom-
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plishments of the controversial American were far from superior. Moreover, in disagreement with results of the 
two historic studies presented above, the findings yielded a clear-cut linear increase in riders’ mean km/h per-
formances from 1934 to 2010 of b = 0.20 km/h per year, which explained R2 = 0.57 (p ≤ 0.001) of the variation 
in riders’ performances. 
The foregoing findings entail that the choice of dependent variable may misrepresent conclusions concerning 
the influence of doping agents on riders’ performance progress over the years. As already proposed by [5], se-
lecting riders’ final performances as the measure to evaluate this influence may be invalid, because the very 
same performances are also the result of joint and coordinated labors of the total group of riders participating in 
the three-week, multi-stage cycling races. Hence, these group labors can be considered confounding variables 
which may strongly hinder a sound assessment of individual riders’ final km/h performances. Unpaced time tri-
aling constitutes the “moment of truth” in cycling. In these races, riders in person compete for the fastest time 
and they cannot profit from the efforts of other riders in the race through drafting. In time trials of 5 - 70 km rid-
ers may deliver exceptional power outputs, ranging between 320 - 450 W [13]. These races therefore demand 
the utmost of individual riders’ aerobic exercise capacity. Consequently, it is reasonable to argue that an assessment 
of these individual performances will raise the likelihood to indirectly identify the influence of banned, ergo-
genic doping aids on riders’ sportive feats over the years. Consistent with Vandeweghe [1], we therefore main-
tain that individual riders’ time trial performances are more valid than final performances to evaluate as to 
whether or not El Helou and colleagues and Perneger are correct in their observations and conclusions. 
1.3. The Texas Sharpshooter Fallacy 
We further argue that conclusions drawn in all three studies (admittedly, including our own) are perhaps un-
sound, because they all could have been subject to the same false logic: The Texas sharpshooter fallacy. This 
informal fallacy derives from a story about a Texan who practiced shooting his gun at the side of a barn located 
in his backyard. He randomly shot at the wall of the barn. After practicing several weeks, he drew a target onto 
the biggest cluster of hits and then claimed to be a sharpshooter. Applied to the observations discussed above, 
the logic illustrates that (“causal?”) conclusions or inferences based on selective or limited data may not be valid. 
In combination with the incorrect choice of dependent variable, this fallacy might explain why findings of the 
three studies strongly contradict each other.  
As noted, our time trial study [12] yielded a linear increase in riders’ time trial performances from 1934 to 
2010. El Helou et al. [4] reported an improvement in riders’ final km/h performances from 1993 to 2008, while 
Perneger [5] described a significant downturn in the km/h achievements of the fifth-ranking riders in the years 
between 2004 and 2009. However, when considering results of the latter two studies, El Helou et al. state that 
the improvement they observed also held for the ten best classified riders in the three Grand Tours. Their sample 
thus includes the achievements of the fifth-ranking riders on which Perneger based his results. Yet, El Helou and 
co-workers did not report a significant downturn in speed after 2004. Finally, Perneger himself states that the 
trends he reported were far from consistent. It was the strongest for the Vuelta, modest for the Tour, and absent 
in the Giro. So, we conclude that findings between all three studies are strongly equivocal.  
This inconsistency can be explicated by different samples, differences in dependent measures, selective statis-
tical analyses, and the use of restricted ranges of observations. Indeed, our own time trial study may have built 
on selective data, since it evaluated km/h performances of riders who faced a limited range of trial distances (50 - 
61 km). It is conceivable that statistical findings could be different, when reckoning the total variation in trial 
distances riders faced in the three major races over time. The 6.38% progress in the fourth relative to the third 
period obtained by [4] is also subject to criticism, owing to the specific way this increase was statistically tested. 
The researchers aggregated all riders’ performances demonstrated in the third period and compared the resulting 
mean performances to the aggregated mean performances of riders in the fourth period. Because they also found 
a strong linear increase in performance from the third to the fourth period, the difference between the two pe-
riods might thus have been influenced by the relatively slower speeds demonstrated by riders in the years fol-
lowing WW II in the third period. Thus, the improvement they reported might be attributed to the selection of 
specific comparison groups. As a final point, Perneger’s findings may be subject to the same fallacy, not only 
because his sample scrutinized a very restricted range of years in which riders competed, but also because he 
might have utilized an invalid dependent variable. 
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2. Research Questions  
To re-assess developments in riders’ progress in speed over the years, we decided to investigate all time trial 
wins demonstrated by riders on flat and rolling terrain in the three European tours from 1933 to 2013. In 1933, 
organizers of the Giro scheduled the first time trial ever in cycling. Our first research question examines whether 
El Helou et al.’s [4] and Perneger’s [5] conclusions hold true. Based on El Helou and co-workers, we expect 
superior performances of riders in the 1990s and thereafter. Building on Perneger, we expect slower perfor-
mances in the period since 2004 compared to the preceding epo era. Our second research question explores 
whether riders’ expected faster or slower performances in the two distinct “critical” periods can be considered 
statistical outliers. 
3. Method 
3.1. Design and Sample 
The annals of the French website “Association Mémoire du Cyclisme” [14] provided all information concerning 
our variables relating to the three tours. As noted, the first time trial ever was scheduled in the 1933 Giro and 
this initiative was immediately followed by the Tour organizers in 1934 and in 1941 by the Vuelta organizers. 
Team time trials, mountain time trials (racing uphill) and prologues were not included in the study, because they 
are considered different sub-disciplines in cycling [12]. The total number of time trials is N = 325. However, 
Van Dyck’s victory in the first time trial of the 1947 Vuelta was not measured in time units, but was awarded 
points. Therefore, we discarded his performance, resulting in N = 324 to conduct analyses. 
3.2. Descriptive Statistics and Correlations 
Descriptive statistics are presented in Table 1, Panels A to C. Regarding the total sample, Panel A shows that 
the trial distances ranged between 2.7 and 139 km (M = 43.83; SD = 19.51). Riders’ mean km/h performances 
varied between 25.81 and 56.22 (M = 45.65; SD = 4.65). We expressed riders’ mean time performances in hours, 
minutes and seconds and they varied between 00:03:02 and 03:49:36 with M = 00:59:00 (SD = 00:30:25). The 
correlation between the two measures, r(324) = −0.50, p ≤ 0.001, indicates a common variance of 25% between 
the two variables. Panel B presents the descriptive statistics for the three tours. Mean trial distances in the three 
races vary, F(2, 322) = 10.69, p ≤ 0.001. Collapsed across trials, distances were significantly larger in the Tour 
compared to the Italian and the Spanish race, which did not differ significantly from each other. Regarding Panel 
C, on the basis of Lodewijkx and Brouwer [11], we partitioned the years of competition into eight different pe-
riods of approximately ten years, accounting for El Helou et al.’s critical year 1993 (period 7). This year served 
as the standard to classify the ten-year periods after WW II. The epo era (period 7) comprises the years between 
1993 and 2002, while Perneger’s years (period 8) constitute the years between 2003 and 2013. Comparisons of 
trial distances between the pre-epo years (across periods 1 to 6) vs. the epo years vs. Perneger’s years produced 
no significant differences, F(2, 322) = 0.68, p = 0.50. 
The correlation between competition year and trial distances, r(325) = −0.19, p ≤ 0.001, indicates a small de-
cline in distances over the years. However, the scatter plot in Panel A of Figure 1 shows that the relationship is 
not linear, but can best be described as an M-curve. Riders faced larger distances in the post-WW II years, 
shorter distances in the 1970s, growing distances in the 1980s, and shorter distances again after 2003. This rela-
tionship entails that we should control for the variation in trial distances when examining our research questions. 
Also, Panel B in Figure 1 shows a nearly perfect relationship between trial distances and riders’ mean time per-
formances, r(324) = 0.97, p ≤ 0.001. As the distances grow larger, riders perform slower. Note that this substan-
tive relationship holds true, regardless of the year in which riders competed and, hence, applies to riders’ wins in 
the epo era (r = 0.97) and Perneger’s years (r = 0.97) as well. We will attend to these robust correlations in more 
detail in the concluding sections of this paper. 
3.3. Analyses 
We initially checked whether the relationship between competition year and riders’ mean km/h performances 
indeed showed any signs of nonlinearity, using the Lowess scatter plot procedure [15], a nonparametric method 
for exploring and estimating nonlinear regression functions. We next statistically tested the same question by  
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Table 1. Descriptive statistics of time trials broken down by grand tours and time periods.                               
Samples N (Trials) Years Distance (km) Mdistance1 Mkm/h (SD)2 Mtime (SD)2 
A: Total Sample 325 1933-2013 2.7 - 139 43.83 45.65 (4.56) 00:59:00 (00:30:25) 
B: Grand Tours       
Tour 129 1934-2013 6 - 139 49.75a 45.32 (4.07) 01:07:20 (00:35:52) 
Giro 99 1933-2013 5 - 81 40.90b 46.51 (3.54) 00:53:19 (00:19:31) 
Vuelta 97 1941-2013 2.7 - 93 38.95b 45.20 (5.85) 00:53:40 (00:29:24) 
C: Time Periods       
1. – 19 1933-1942 27 - 90 52.75 38.14 (4.68) 01:25:33 (00:30:25) 
2. – 22 1945-1952 14 - 139 72.18 39.01 (3.61) 01:52:23 (00:50:40) 
3. – 35 1953-1962 5 - 85 50.14 43.50 (3.43) 01:09:50 (00:31:19) 
4. – 52 1963-1972 2.7 - 67 33.05 44.30 (3.72) 00:46:07 (00:27:58) 
5. – 54 1973-1982 3.8 - 72 32.51 45.91 (2.42) 00:42:43 (00:18:55) 
6. – 50 1983-1992 22 - 87.5 47.08 47.05 (2.55) 01:00:23 (00:19:59) 
Pre-Epo Years (Total) 232 1933-1992 2.7 - 139 43.85a 44.16 (4.29) 01:01:16 (00:34:50) 
7. Epo Years 47 1993-2002 28 - 64 46.12a 49.34 (2.30) 00:56:10 (00:11:41) 
8. Perneger’s Years 46 2003-2013 14.4 - 57 41.40a 49.34 (3.17) 00:50:29 (00:14:01) 
Notes: 1Within panels, means without a common superscript differ significantly, p ≤ 0.05. For time periods, the pre-epo years (collapsed across time 
periods 1 - 6), were contrasted with the epo and Perneger’s years. 2Km/h = kilometers per hour performance; time = time performance in hours, minutes 
and seconds. Both performance measures are based on N = 324. 
 
  
(a)                                                      (b) 
Figure 1. Lowess scatter plots of the relationships between competition year and trial distances (Panel a) and between trial 
distances and mean time performances (Panel b).                                                                
 
linear regression analyses (OLS). Reckoning the variation in trial distances over time, we decided to control for 
the influence of this variable in the analyses, as well as for differences between races and the interaction effects 
between Competition Year × Distance, Competition Year × Races, and Distance × Races. To these ends, we 
mean centered the interval variables (Myear = 1978; Mdistance = 43.83 km) and effect-coded the races variable: 
First contrast Tour = 1, Giro = −1, Vuelta = 0; second contrast Tour = 0, Giro = 1, Vuelta = −1. 
Regarding our second research question, as follow–up of the regression analyses we examined whether riders’ 
estimated residual performances can be considered outliers, concentrating on performances realized by riders in 
the 1990s and thereafter. To settle on outliers, we used the rather stringent criterion of z ≥ ±1.96 (±2SD) instead 
of the generally accepted ±3SD-criterion (or z ≥ ±3.30; [16]). The same analysis will also produce information 
concerning influential cases—such as extremely fast or slow performances, and large or small trial distances— 
that may have put the stability and validity of the regression findings at risk. Given the current data, the critical 
leverage value to decide on influential cases is h ≥ 0.09 [16]. We analyzed data by IBM-SPSS® (v. 20). 
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4. Results 
4.1. Progress over Time  
Figure 2 presents the Lowess scatter plot of the relationship between competition year and riders’ mean km/h 
performances. The correlation between the two variables, r(324) = 0.71 (R2 = 0.50, p ≤ 0.001), designates that 
riders race faster over time. The plot reveals a straightforward linear progress in performance with no signs of 
any nonlinear deviations in the epo era and in Perneger’s years. The same plot additionally shows that riders’ 
achievements in the two critical periods show a strong variation, characterized by fast as well as slow perfor-
mances.  
Results of the linear regression analyses are summarized in Table 2. The nine variables included in the equa-
tion explained 2adjR  = 0.604 of the variation in riders’ performances. The linear influence of competition year 
proved to be the strongest of all variables, indicating that riders race b = 0.16 km/h faster per year. Furthermore, 
larger trial distances are associated with a decrease of b = −0.03 km/h in speed to a kilometer increase in dis-
tance. Yet, the influence of this variable is less substantive relative to the influence of competition year, pre-
sumably owing to the fact that the mean km/h performance measure (as the dependent variable) already includes 
the distance variable. Table 2 further reveals no significant difference in average speed between the Tour and 
the Giro, whereas the mean speed in the Giro is b = 1.47 km/h faster than in the Vuelta. Table 2 additionally 
shows that the five interaction effects together explained 2adjR  = 0.060 of the variation in km/h performances. 
The interaction effect between Competition Year × Distance (A × B) did not produce a significant effect. The 
analyses also yielded no differences between the French and the Italian race in interaction with competition year 
and trial distances (A × C and B × C), while the interaction effects of the latter variables with the Giro and the 
Vuelta were significant (A × D and B × D), explaining ∆R2 = 0.01 - 0.036 of the differences in riders’ speed. 
Auxiliary simple slopes analyses of the A × D-interaction effect revealed that in the Vuelta the speed progress 
over time is faster (b = 0.21 km/h per year) relative to the Giro (b = 0.11 km/h per year). For the Tour the 
progress is intermediate (b = 0.16 km/h per year). Figure 3 presents the A × D-interaction effect. It shows that 
the Italian race is characterized by a strikingly regular yearly progress in performance compared to the other two 
races, while performances are comparatively slower in the early years of the Spanish race compared to the Giro. 
Closer scrutiny of the B × D-interaction effect indicated that trial distances in the Spanish race are associated 
with somewhat slower performances to a kilometer increase in distance (b = −0.10 km/h) than in the Giro (b = 
−0.03 km/h). Again, the relationship is intermediate in the French race (b = −0.06 km/h). Last, Table 2 indicates 
no sign of multicollinearity among the predictor variables, since none of them approached the critical bench-
mark for tolerance (0.1 - 0.2) which is considered a cause for concern [16]. This adds validity to our findings. 
Most relevant for our first research question is the strong linear relationship we found between competition 
year and riders’ winning performances. Figure 4 presents the partial regression plot of this relationship with 
95%-CI. In disagreement with conclusions presented by El Helou and colleagues, the 1990s are not characte-
rized by nonlinear, superior performances compared to performances demonstrated by riders in preceding years. 
Furthermore, inconsistent with Pernerger’s conclusion, Figure 4 also illustrates that riders’ performances do not 
level off going from 2003 to 2013. Rather, they show a clear-cut linear progress in speed in this era compared to 
the foregoing epo years. This linear progress is in line with findings we discussed earlier relating to the Lowess 
scatter plot (see Figure 2).  
To validate these conclusions, we conducted two supplementary analyses. Inspired by El Helou et al., in a 
first analysis we compared riders’ performances in the pre-epo years (across periods 1 to 6) to performances of 
riders in the epo years (period four). Table 1 shows that performances in the epo years (Mkm/h = 49.34) at first 
were faster than performances in the pre-epo years (Mkm/h = 44.16; R2 = 0.189, p ≤ 0.001). After controlling for 
the influence of year of competition (b = 4.60 km/h) and trial distances (b = −0.096 km/h) on the rider-km/h 
performance relationship, the main effect was not significant anymore, revealing that riders in the epo years 
(Mkm/h = 45.59) raced 0.67 km/h faster than riders in the pre-epo years (Mkm/h = 44.92; 2adjR  = 0.004, p = 0.30). 
The relative progress in speed of riders in the epo years equals 1.5%. In the second analysis we evaluated per-
formances in the epo years against performances in Perneger’s years. Table 1 shows no initial performance dif-
ferences between the two groups (Mkm/h = 49.34, p = 1.00). However, after adjusting this main effect for the in-
fluence of competition year (b = −0.83 km/h) and trial distances (b = −0.06 km/h), findings revealed that riders 
in Perneger’s years (Mkm/h = 49.79) outperformed riders in the epo years (Mkm/h = 48.90) with 0.89 km/h ( 2adjR  = 
0.007, p = 0.42). This progress in speed amounts to 1.8%. Notice that the slight performance differences we  
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Table 2. Mean km/h performances regressed on competition year, trial distances, races, and interaction effects (N = 324).      
Effects Variables b SE β ∆R2 2adjR  Tolerance 
 Intercept 45.39*** 0.19 - - - - 
Main effects 
Comp. year (A) 0.16*** 0.01 0.71 0.502 
0.549*** 
0.93 
Distance (B)  −0.03** 0.01 −0.13 0.024 0.51 
Tour vs. Giro (C) 0.28 0.24 0.05 0.002 0.66 
Giro vs. Vuelta (D) 1.47*** 0.27 0.25 0.025 0.58 
Interaction 
effects 
A × B 0.01 0.01 0.08 0.005 
0.060*** 
0.52 
A × C −0.01 0.01 −0.01 0.010 0.63 
A × D −0.06*** 0.01 −0.20 0.036 0.71 
B × C 0.01 0.01 0.05 0.001 0.61 
B × D 0.04** 0.01 0.12 0.010 0.65 
Total - - - - - 0.604*** - 
Notes: Degrees of freedom vary between df = 1, 314 and df = 9, 314. b and SE are in kilometers per hour per year, or per kilometer increase in trial 
distance. **p ≤ 0.01; ***p ≤ 0.001 
 
 
Figure 2. Lowess scatter plot of the relationship between year of competition and riders’ mean km/h performances in time 
trials (N = 324). P2 to P4 present time periods distinguished by El Helou et al. The dotted line indicates the start of 
Perneger’s years (2003).                                                                                         
 
 
Figure 3. Regression plot of the relationship between year of competition and riders’ estimated mean km/h performances in 
time trials in the Tour (▲), Giro (■), and Vuelta (●). The figure illustrates the interaction effect between Giro/Vuelta and 
competition year (A × D).                                                                                  
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Figure 4. Partial regression plot of the relationship between year of competition and riders’ estimated mean km/h 
performances in time trials (N = 324) with 95%-CI. Variables are mean centered. P2 to P4 present time periods distinguished 
by El Helou et al. The dotted line indicates the start of Perneger’s years (2003). Fast performances beyond the 95%-CI are 
indicated by . ☼ indicates the performance of Roger Rivière in the 1959 Vuelta which genuinely can be regarded an outlier 
(see Table 3).  presents Plaza’s performance in the 2005 Vuelta.                                                  
 
obtained between the various comparison groups did not yield significant results. Still, they are indicative of the 
linear progress in speed we discussed previously. The results of these supplementary analyses thus agree with 
conclusions we drew earlier concerning research question one. 
4.2. Outliers and Influential Cases 
In answer to our second research question, Table 3 provides a summary of outliers and influential cases. It 
presents a total of 26 riders of whom eighteen demonstrated rather fast or slow residual performances beyond 
the 95%-CI and seven had large leverage values (h ≥ 0.09). The last column in the table shows that the latter 
values all concern riders who either faced extremely long or short trials. Returning to riders’ slow and fast per-
formances, Table 3 indicates that seven riders demonstrated comparatively fast residual performances. Yet, in-
consistent with expectations based on El Helou et al., only one (1.1%) of the 93 riders who performed in their 
critical years realized such an achievement: Spanish rider Ruben Plaza who achieved a formidable 56.22 km/h in 
his 38.9 km-long trial in the 2005 Vuelta (see Figure 4).  
Eleven of the eighteen cyclists raced rather slowly. Only four (8.7%) of the 46 riders in Pernerger’s years de-
livered such performances: Bruseghin (Giro, 2008); Dowsett (Giro, 2013); Kessiakoff (Vuelta, 2012); and Can-
cellara (Vuelta, 2013). In conclusion, since a total of five (5.4%) of the 93 riders in the two critical periods we 
distinguished delivered comparatively slow or fast performances that surpassed the 95%-bandwidth, it is safe to 
state that our findings disprove our second research question.  
5. Discussion  
In disagreement with expectations based on [4] and [5], our findings yielded no support for our first research 
question. When taking time trial performances rather than final performances as the criterion, there is no evi-
dence for nonlinear in- or declines in riders’ speed beyond the 1990s. Across the three main European stage rac-
es, riders’ mean km/h performances are characterized by a steady linear progress of 160 m per year and their 
achievements in the 1990s and 2000s are no exemption to this development. Inconsistent with observations of 
[4], the progress in speed we observed from the pre-epo to the epo era amounted to 1.5%, and not 6.38%. In a 
similar vein, not in line with [5], riders did not show a downturn in speed since 2003. Rather, they realized a 
progress in speed of 1.8% compared to riders in the epo era. We additionally found that the linear progress in  
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Table 3. Casewise diagnostics of riders with slow or fast residual km/h performances and influential cases.                 
Rider Race (Year) Distance Observed km/h 
Predicted 
km/h 
Residual 
km/h z Leverage (h) 
Impanis Tour (1947) 139 36.32 37.58 −0.26 −0.09 0.18 
Lambrecht Tour (1948) 120 41.08 37.69 3.38 1.18 0.11 
Coppi Tour (1949) 137 37.56 37.15 0.41 0.14 0.15 
LeMond Tour (1989) 24.5 54.55 47.53 7.02 2.45 0.03 
Coppi Giro (1951) 81 39.12 42.87 −3.76 −1.31 0.12 
Coppi Giro (1952) 35 34.25 44.27 −10.02 −3.50 0.03 
Poblet Giro (1960) 5 46.15 45.59 0.57 0.20 0.11 
Ventarelli Giro (1960) 25 38.43 45.19 −6.76 −2.36 0.04 
Merckx Giro (1969) 49.3 39.84 45.62 −5.78 −2.02 0.01 
Boifava Giro (1971) 28 38.92 46.04 −7.12 −2.48 0.02 
Bruseghin Giro (2008) 39.4 41.71 49.38 −7.68 −2.68 0.03 
Dowsett Giro (2013) 54.8 43.01 50.30 −7.30 −2.55 0.07 
Rodriguez Vuelta (1941) 53 28.14 35.47 −7.33 −2.56 0.05 
Rodriguez Vuelta (1942) 53 25.80 35.69 −9.88 −3.45 0.05 
Langarica Vuelta (1946) 53 30.31 36.56 −6.25 −2.18 0.04 
Van Dyck Vuelta (1947) 47 45.05 37.38 7.67 2.68 0.04 
Ruiz Vuelta (1948) 14 40.45 40.85 −0.40 −0.14 0.09 
Capo Vuelta (1950) 93 37.43 33.56 3.87 1.35 0.14 
Magni Vuelta (1955) 29 50.48 40.74 9.74 3.40 0.04 
Lorono Vuelta (1957) 85 38.28 36.08 2.20 0.77 0.09 
Rivière Vuelta (1959) 62 51.15 38.61 12.54 4.37 0.04 
Gonz.-Linares Vuelta (1971) 2.7 52.42 45.92 6.50 2.27 0.06 
Merckx Vuelta (1973) 10.5 52.35 45.67 6.68 2.33 0.04 
Plaza Vuelta (2005) 38.9 56.22 50.11 6.11 2.13 0.02 
Kessiakoff Vuelta (2012) 39.4 44.94 51.53 −6.59 −2.30 0.03 
Cancellara Vuelta (2013) 38.8 45.65 51.76 −6.11 −2.13 0.04 
Notes: In bold type face are riders with relatively fast residual performances with z ≥ +1.96. Influential cases: leverage h ≥ 0.09. 
 
performance varied between races. It is significantly faster in the Spanish than in the Italian race, while no sig-
nificant differences emerged between the French and the Italian race.  
We also did not find evidence for our second research question. In disagreement with El Helou and colleagues, 
only one of the 93 riders in their critical era delivered a rather fast performance: Ruben Plaza in the 2005 Vuelta. 
However, it can be doubted whether his achievement can be regarded extremely fast. Not only because we took 
the rather rigorous standard of +2SD to evaluate conspicuous performances, but also because the circumstances 
during the trial must have been very favorable. To illustrate, closer inspection of the classification of the trial 
revealed that Alberto Ongarato, who reached the 100th position, already raced at a speed of nearly 50 km/h [14]. 
Likewise, only four of the 46 riders in Perneger’s era demonstrated relatively slow wins beyond the 95%-con- 
fidence interval. It remains to be seen whether these performances can be attributed to the successes of WADA’s 
anti-doping measures, as suggested by Perneger. Alternatively, they can also be reasonably explicated by unfa-
vorable weather, road and terrain conditions, which are of the utmost importance in unpaced time trialing [17]. 
In our case, all four riders faced extremely hilly courses, a circumstance which reduced their overall speed con-
siderably.  
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Implications and Comments 
How can we settle these findings with generally shared opinions concerning, for instance, the proposed powerful 
ergogenic effects of epo doping on cyclists’ performances? Our reply would be that this relationship is overva-
lued [18] [19] and might even lack scientific evidence [20]. To critically examine the strength of this relation-
ship, Lodewijkx et al. [19] conducted a meta-analysis on the findings of seventeen laboratory studies that hi-
therto investigated this relationship. In these studies, participants were treated with epo or not. The studies sub-
sequently assessed the degree of performance improvement attributable to epo administration, measured by 
maximal oxygen uptake (VO2max) and maximal aerobic power output (Wmap). The analysis yielded modest effect 
sizes, d = 0.41 - 0.49, r = 0.19 - 0.44 and r2 = 0.04 - 0.19, indicating that a considerable 81% - 96% of the dif-
ferences in performance improvement observed in the studies cannot be attributed to epo administration. The 
largest epo-induced improvement in VO2max yielded by the analysis equaled an increase in speed of about 1 
km/h. Perneger [5] arrives at the same conclusion concerning this improvement in speed. However, we emphas-
ize that this slight increase is solely restricted to laboratory situations. It is a well-known fact that such im-
provements cannot be directly extrapolated to multi-stage cycling races that last three weeks [19]-[21]. All these 
observations imply that judgments pertaining to the strong ergogenic effects of epo doping on aerobic exercise 
capacity are far from conclusive. In turn, this means that the relationship between epo doping and performances 
of endurance athletes such as cyclists in real contests is overestimated too. In our view, this constitutes the most 
parsimonious explanation for the null results we obtained regarding riders’ expected superior time trial perfor-
mances in the epo era.  
Moreover, the differences in progress in speed between races we found also put great pressure on conclusions 
drawn in previous historic studies. Notice that Perneger [5] reported similar trends in his study. This variation is 
inconsistent with generalizing statements pertaining to the hypothesized strong effects of epo doping used by 
riders in the three tours in the last twenty years. For instance, how can such statements be reconciled with the 
prominent regular performance progress observed in the Italian race? Additionally, arguing from the same pers-
pective, it is also inconsistent to explain the very same differences by referring to riders’ use of different doping 
agents in the three races as an explanatory variable. Another explanation for these differences, suggested by [5], 
concerns the assumed, rather lenient attitudes to adhere to and to put into practice WADA’s anti-doping regula-
tions in the different countries. However, the real reasons to clarify these differences might be much more mun-
dane. For instance, the faster yearly progress in the Vuelta vs. the Giro we found, can mainly be attributed to the 
rather slow performances realized by riders in the early years of the Spanish race (see Figure 3). During these 
years, the Vuelta struggled with civil war and the Franco regime, a deep economic recession, a competition 
which for many years restricted itself to local Spanish riders and did not include more famous and very competi-
tive foreign Italian and French riders, and, last, sometimes extremely bad weather, race and road conditions [22].  
The same problems arise when trying to elucidate the nearly perfect correlation we obtained between trial 
distances and riders’ mean time performances, r = 0.97. As a single variable, trial distances are responsible for a 
substantive 94% of the performance differences between riders over the years, leaving 6% of these differences 
unexplained. We already described that this strong relationship is not influenced by the years in which riders 
competed and thus applies to riders’ wins in the epo era and the years thereafter. In descriptive terms, some stu-
dies suggest that the ergogenic effects of epo doping on aerobic exercise capacity are “dramatic” [23], whereas 
effects of blood transfusions are labeled “gigantic” in a recent study by Lundby, Robach and Saltin [24]. How-
ever, if these observations were valid, one would expect the trial distance–time performance relationship to be 
strongly moderated by the years in which riders won their trial, most notably the 1990s. Yet, this is not what our 
findings tell us.  
Last, it is a rather biased and circular way of reasoning to mainly concentrate on riders’ performances in the 
epo era and to try to find explanations for these achievements, thereby completely ignoring comparable ad-
vances in foregoing years. In our view, the simplest explanations for the performance improvement over time 
we found, concern winning riders’ outstanding athletic capacities combined with other facilitative, performance- 
enhancing factors such as more favorable road, terrain and race conditions, less demanding racing programs, 
growing insights from exercise physiology, more sophisticated and effective training regimes, improved tech-
nology of bikes and racing gear, increased specialization of riders, growing commercial interests with concomi-
tant increases in financial incentives and pressures to perform, and improvements in nutrition and hydration, 
leading to an enhanced maintenance of riders’ energy balance during stage events.  
H. F. M. Lodewijkx, P. Verboon 
 
OALibJ | DOI:10.4236/oalib.1101045 11 November 2014 | Volume 1 | e1045 
 
6. Conclusion 
To conclude, findings of the current study corroborate our comments [10]-[12] on previous archival studies, 
which examined effects of doping use and anti-doping efforts on riders’ final km/h performances in the three 
major European races in the years of the “epo epidemic” and thereafter. As suggested in the Introduction of this 
paper, the choice of an incorrect dependent variable combined with the Texas sharpshooter fallacy may indeed 
have led to biased conclusions relating to these developments. When reckoning individual riders’ time trial per-
formances, our findings compellingly revealed there is no solid evidence whatsoever that justifies making any 
such statements.  
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